Achillion Reports Third Quarter and Nine Month 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Achillion Pharma (ACHN) Posts Narrower-than-Expected Q3 Loss
November 4, 2014 6:32 AM ESTAchillion Pharma (NASDAQ: ACHN) reported Q3 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.
... More